Evidence map›Paper›PMID 32369396›Full record

ArticleAmerican journal of respiratory and critical care medicine2020

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection.

Roham T Zamanian, Charles V Pollack, Michael A Gentile, Moira Rashid, John Christian Fox, Kenneth W Mahaffey, Vinicio de Jesus Perez

Open access · hybridAbstract readCase ReportsLetter
In one paragraph

Article in American journal of respiratory and critical care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Development of a light-induced gas phase nitric oxide generator and its use in killing biofilm bacteria in vitro and ex vivo.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Utility of NO and HNitric oxide : biology and chemistry · 2022
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Reply to "Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium".The journal of allergy and clinical immunology. In practice · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Roham T ZamanianStanford University School of MedicineStanford, California.
Charles V PollackUniversity of Mississippi School of MedicineJackson, Mississippi.
Michael A GentileVero BiotechAtlanta, Georgia.
Moira RashidPrivate Practice Long Beach, Californiaand.
John Christian FoxUniversity of California Irvine Emergency MedicineOrange, California.
Kenneth W MahaffeyStanford University School of MedicineStanford, California.
Vinicio de Jesus PerezStanford University School of MedicineStanford, California.
Stanford University · USCalifornia State University, Long Beach · USUniversity of California, Irvine · USUniversity of Mississippi · USVERO Biotech (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, InhalationAdultBetacoronavirusCoronavirus InfectionsCOVID-19Familial Primary Pulmonary HypertensionFemaleHumansInvestigational New Drug ApplicationNitric OxideOff-Label UseOutpatientsPandemicsPneumonia, ViralSARS-CoV-2TelemedicineNitric Oxide

Identifiers

PMID32369396
PMCPMC7328330
OpenAlexW3022461473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.